BRIEF-Longboard Capital Advisors reports 6.58 pct passive stake in Imprimis Pharmaceuticals

* Longboard Capital Advisors reports 6.58 percent passive

stake in Imprimis Pharmaceuticals Inc as on March 21, 2017

Source text:(http://bit.ly/2mP5PVu)

Further company coverage:

Read more